Digest Network Come funziona
Network
/
Società
Av
Non verificato

Avextra Pharma GmbH

Di cosa scriviamo

FarmaceuticaMedicina Salute Benessere

6 comunicati stampa

Guarda tutti i comunicati
24/10/2025
Farmaceutica
Medicina Salute Benessere
Avextra supporta in Italia uno studio clinico di fase II sulla cannabis terapeutica nelle malattie neurodegenerative
Fonte
Avextra Pharma GmbH
Emittente
GLOBENEWSWIRE
1.00
0
24/10/2025
Farmaceutica
Medicina Salute Benessere
Avextra Supports Phase II Clinical Trial in Italy on Cannabis-based medicines for Neurodegenerative Diseases
Fonte
Avextra Pharma GmbH
Emittente
GLOBENEWSWIRE
1.00
0
12/06/2025
Farmaceutica
Avextra Cannabis extract can potentially reduce symptom burden for late palliative patients
Fonte
Avextra Pharma GmbH
Emittente
GLOBENEWSWIRE
1.00
0
14/03/2025
Farmaceutica
Avextra Showcases Study Findings on World Sleep Day 2025
Fonte
Avextra Pharma GmbH
Emittente
GLOBENEWSWIRE
1.00
0
12/03/2025
Farmaceutica
Avextra Unveils Promising Study Results at Major Pain Congress
Fonte
Avextra Pharma GmbH
Emittente
GLOBENEWSWIRE
1.00
0
20/12/2024
Farmaceutica
Avextra Backs Landmark Psilocybin Therapy Study in Palliative Care
Fonte
Avextra Pharma GmbH
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0